Overview
Franck Schurhoff practices in Creteil, France. Mr. Schurhoff is rated as a Distinguished expert by MediFind in the treatment of Schizophrenia. His top areas of expertise are Schizophrenia, Abdominal Obesity Metabolic Syndrome, Metabolic Syndrome, and Bipolar Disorder (BPD).
His clinical research consists of co-authoring 147 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 111 articles and participated in 1 clinical trial in the study of Schizophrenia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- SchizophreniaMr. Schurhoff isDistinguished. Learn about Schizophrenia.
- Advanced
- Abdominal Obesity Metabolic SyndromeMr. Schurhoff isAdvanced. Learn about Abdominal Obesity Metabolic Syndrome.
- Metabolic SyndromeMr. Schurhoff isAdvanced. Learn about Metabolic Syndrome.
- Experienced
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder (BPD)Mr. Schurhoff isExperienced. Learn about Bipolar Disorder (BPD).
- Drug Induced DyskinesiaMr. Schurhoff isExperienced. Learn about Drug Induced Dyskinesia.
- Major DepressionMr. Schurhoff isExperienced. Learn about Major Depression.
- NecrosisMr. Schurhoff isExperienced. Learn about Necrosis.
- Neurotoxicity SyndromesMr. Schurhoff isExperienced. Learn about Neurotoxicity Syndromes.